Immunological treatments for autism - PubMed

Immunological treatments for autism

S Gupta. J Autism Dev Disord. 2000 Oct.

Abstract

Several investigators, including ourselves, have reported significant changes in various immune responses in children with autism. These changes demonstrate dysregulation of the immune system (deficiency in some components of the immune system and excesses in others). In addition, certain genes in the major histocompatibility complex (that regulates immune responses) appear to be involved in autism. Based upon immunological abnormalities, various treatment modalities have been applied to children with autism. In this brief review, these immunological changes and various biological therapies are analyzed and summarized.

Similar articles

• Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin.

  Gupta S, Samra D, Agrawal S. Gupta S, et al. J Clin Immunol. 2010 May;30 Suppl 1(Suppl 1):S90-6. doi: 10.1007/s10875-010-9402-9. J Clin Immunol. 2010. PMID: 20393790 Free PMC article.

• Pentoxifylline: brief review and rationale for its possible use in the treatment of autism.

  Gupta S, Rimland B, Shilling PD. Gupta S, et al. J Child Neurol. 1996 Nov;11(6):501-4. doi: 10.1177/088307389601100622. J Child Neurol. 1996. PMID: 9120235 Review. No abstract available.

• Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.

  Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S. Akhondzadeh S, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):32-6. doi: 10.1016/j.pnpbp.2009.09.012. Epub 2009 Sep 20. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19772883 Clinical Trial.

• Brief report: a pilot open clinical trial of intravenous immunoglobulin in childhood autism.

  DelGiudice-Asch G, Simon L, Schmeidler J, Cunningham-Rundles C, Hollander E. DelGiudice-Asch G, et al. J Autism Dev Disord. 1999 Apr;29(2):157-60. doi: 10.1023/a:1023096728131. J Autism Dev Disord. 1999. PMID: 10382136 Clinical Trial. No abstract available.

• Novel treatments for autistic spectrum disorders.

  Levy SE, Hyman SL. Levy SE, et al. Ment Retard Dev Disabil Res Rev. 2005;11(2):131-42. doi: 10.1002/mrdd.20062. Ment Retard Dev Disabil Res Rev. 2005. PMID: 15977319 Review.

Cited by

• Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin.

  Gupta S, Samra D, Agrawal S. Gupta S, et al. J Clin Immunol. 2010 May;30 Suppl 1(Suppl 1):S90-6. doi: 10.1007/s10875-010-9402-9. J Clin Immunol. 2010. PMID: 20393790 Free PMC article.

• Family analysis of immunoglobulin classes and subclasses in children with autistic disorder.

  Spiroski M, Trajkovski V, Trajkov D, Petlichkovski A, Efinska-Mladenovska O, Hristomanova S, Djulejic E, Paneva M, Bozhikov J. Spiroski M, et al. Bosn J Basic Med Sci. 2009 Nov;9(4):283-9. doi: 10.17305/bjbms.2009.2780. Bosn J Basic Med Sci. 2009. PMID: 20001993 Free PMC article.

• Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families.

  Akins RS, Angkustsiri K, Hansen RL. Akins RS, et al. Neurotherapeutics. 2010 Jul;7(3):307-19. doi: 10.1016/j.nurt.2010.05.002. Neurotherapeutics. 2010. PMID: 20643384 Free PMC article. Review.

• Brain effects of chronic IBD in areas abnormal in autism and treatment by single neuropeptides secretin and oxytocin.

  Welch MG, Welch-Horan TB, Anwar M, Anwar N, Ludwig RJ, Ruggiero DA. Welch MG, et al. J Mol Neurosci. 2005;25(3):259-74. doi: 10.1385/JMN:25:3:259. J Mol Neurosci. 2005. PMID: 15800379

• Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old.

  Wasilewska J, Kaczmarski M, Stasiak-Barmuta A, Tobolczyk J, Kowalewska E. Wasilewska J, et al. Arch Med Sci. 2012 May 9;8(2):324-31. doi: 10.5114/aoms.2012.28561. Arch Med Sci. 2012. PMID: 22662007 Free PMC article.

References

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database